Swiss National Bank Prothena Corp Public LTD CO Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Swiss National Bank holds 68,700 shares of PRTA stock, worth $989,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,700
Previous 68,700 -0.0%
Holding current value
$989,280
Previous $1.42 Million 18.91%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$19.54 - $26.15 $205,170 - $274,575
-10,500 Reduced 13.26%
68,700 $1.42 Million
Q4 2023

Feb 06, 2024
SELL
$32.31 - $52.32 $252,018 - $408,096
-7,800 Reduced 8.97%
79,200 $2.88 Million
Q3 2023

Nov 08, 2023
BUY
$47.3 - $70.6 $52,030 - $77,660
1,100 Added 1.28%
87,000 $4.2 Million
Q2 2023

Aug 09, 2023
BUY
$48.26 - $78.59 $617,728 - $1.01 Million
12,800 Added 17.51%
85,900 $5.87 Million
Q1 2023

May 10, 2023
SELL
$46.97 - $58.27 $291,214 - $361,274
-6,200 Reduced 7.82%
73,100 $3.54 Million
Q4 2022

Feb 08, 2023
BUY
$52.05 - $65.0 $109,305 - $136,500
2,100 Added 2.72%
79,300 $4.78 Million
Q1 2022

May 09, 2022
BUY
$30.27 - $49.22 $236,106 - $383,916
7,800 Added 11.24%
77,200 $2.82 Million
Q4 2021

Feb 08, 2022
BUY
$42.11 - $73.26 $46,321 - $80,586
1,100 Added 1.61%
69,400 $3.43 Million
Q3 2021

Nov 08, 2021
BUY
$48.2 - $78.89 $322,940 - $528,563
6,700 Added 10.88%
68,300 $4.87 Million
Q2 2021

Aug 06, 2021
BUY
$21.63 - $57.65 $49,749 - $132,595
2,300 Added 3.88%
61,600 $3.17 Million
Q1 2021

May 07, 2021
BUY
$11.0 - $28.24 $15,400 - $39,536
1,400 Added 2.42%
59,300 $1.49 Million
Q2 2020

Aug 05, 2020
SELL
$9.56 - $12.51 $186,420 - $243,945
-19,500 Reduced 25.19%
57,900 $606,000
Q1 2020

May 08, 2020
BUY
$7.54 - $15.77 $7,540 - $15,770
1,000 Added 1.31%
77,400 $828,000
Q4 2019

Feb 06, 2020
BUY
$7.48 - $17.01 $16,456 - $37,422
2,200 Added 2.96%
76,400 $1.21 Million
Q2 2019

Aug 02, 2019
BUY
$8.85 - $12.49 $14,160 - $19,984
1,600 Added 2.2%
74,200 $784,000
Q1 2019

May 10, 2019
BUY
$10.32 - $14.49 $22,704 - $31,878
2,200 Added 3.13%
72,600 $881,000
Q4 2018

Feb 13, 2019
BUY
$8.73 - $13.74 $34,920 - $54,960
4,000 Added 6.02%
70,400 $725,000
Q4 2017

Feb 07, 2018
BUY
$35.44 - $63.76 $99,232 - $178,528
2,800 Added 4.4%
66,400 $2.49 Million
Q3 2017

Nov 03, 2017
BUY
$53.83 - $67.75 $3.42 Million - $4.31 Million
63,600
63,600 $4.12 Million

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $676M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email